Compounds of the formula (I), wherein R1, R2, R3, R4, R5 and p are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes
-
Page/Page column 53
(2008/06/13)
More Articles about upstream products of 78210-66-9